BKV (NYSE:BKV) Stock Price Expected to Rise, Truist Financial Analyst Says

Key Points

• Truist Financial raised BKV’s price target to $34 from $33 and maintained a “Buy” rating, implying 48.75% upside from the prior close. Analysts overall assign the stock an average “Buy” rating with a $33.67 target.
• BKV shares fell 6.5% to $22.86, despite the company recently reporting quarterly EPS of $0.46—well above the $0.25 consensus estimate—and revenue of $465.54 million versus expectations of $355.25 million.
• Institutional interest has increased, including new stakes from BlackRock and William Blair, while company insiders sold 35,626 shares worth approximately $901,589 over the past three months.

BKV (NYSE:BKV - Get Free Report) had its target price boosted by equities researchers at Truist Financial from $33.00 to $34.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a "buy" rating on the stock. Truist Financial's price target points to a potential upside of 48.75% from the company's previous close.

BKV has been the subject of a number of other reports. Wall Street Zen raised shares of BKV from a "strong sell" rating to a "sell" rating in a research report on Saturday, September 19th. Zacks Research upgraded shares of BKV from a "hold" rating to a "strong-buy" rating in a report on Tuesday, October 6th. Jefferies Financial Group reaffirmed a "buy" rating and set a $34.00 target price on shares of BKV in a research note on Friday, July 10th. Weiss Ratings raised shares of BKV from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday, October 8th. Finally, Barclays lowered their target price on shares of BKV from $36.00 to $35.00 and set an "overweight" rating for the company in a report on Tuesday, September 15th. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $33.67.

BKV Stock Down 6.5%

BKV traded down $1.58 during trading on Wednesday, reaching $22.86. The stock had a trading volume of 1,024,461 shares, compared to its average volume of 1,105,116. The stock's 50 day moving average is $24.17 and its two-hundred day moving average is $25.99. The company has a current ratio of 1.15, a quick ratio of 1.10 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $2.50 billion, a price-to-earnings ratio of 8.33 and a beta of 1.13. BKV has a one year low of $20.08 and a one year high of $32.81.

BKV (NYSE:BKV - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.46 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.21. The firm had revenue of $465.54 million for the quarter, compared to analysts' expectations of $355.25 million. BKV had a net margin of 17.73% and a return on equity of 6.67%. As a group, analysts expect that BKV will post 1.62 earnings per share for the current year.

Insider Activity

In related news, insider Lindsay B. Larrick sold 10,000 shares of the company's stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $26.16, for a total value of $261,600.00. Following the transaction, the insider owned 83,925 shares in the company, valued at $2,195,478. The trade was a 10.65% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Javier Hinojosa sold 12,377 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $25.73, for a total transaction of $318,460.21. Following the sale, the senior vice president directly owned 84,276 shares in the company, valued at $2,168,421.48. This trade represents a 12.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 35,626 shares of company stock worth $901,589 over the last three months. 2.51% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of BKV during the second quarter valued at approximately $74,241,000. Cooper Creek Partners Management LLC raised its holdings in BKV by 24.7% in the 1st quarter. Cooper Creek Partners Management LLC now owns 2,103,230 shares of the company's stock worth $59,984,000 after acquiring an additional 416,281 shares during the last quarter. William Blair Investment Management LLC bought a new position in BKV in the 2nd quarter valued at approximately $32,689,000. Value Aligned Research Advisors LLC lifted its position in BKV by 110.5% in the 2nd quarter. Value Aligned Research Advisors LLC now owns 679,899 shares of the company's stock valued at $18,602,000 after acquiring an additional 356,848 shares in the last quarter. Finally, Bank of America Corp DE purchased a new stake in BKV during the 2nd quarter valued at $16,177,000.

About BKV

BKV Corporation is an energy company focused on natural gas production and related energy-transition solutions. The company explores for, develops and produces natural gas and natural gas liquids, with operations primarily centered in major U.S. shale basins.

BKV's activities include upstream oil and gas development, natural gas marketing and midstream services. The company also develops carbon capture, utilization and storage projects intended to reduce emissions associated with natural gas production and use, as well as renewable natural gas initiatives.

Based in Denver, Colorado, BKV serves U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.